AJANTA PHARMA
Back to Cashflow Statement
|
AJANTA PHARMA Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹-68 Cr | ₹47 Cr | ₹-201 Cr | ₹124 Cr | ₹28 Cr |
What is the latest Net Cash Inflow / Outflow ratio of AJANTA PHARMA ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2026 | ₹-68 Cr |
| Mar2025 | ₹47 Cr |
| Mar2024 | ₹-201 Cr |
| Mar2023 | ₹124 Cr |
| Mar2022 | ₹28 Cr |
How is Net Cash Inflow / Outflow of AJANTA PHARMA Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2026 | ₹-68 Cr | Negative | |
| Mar2025 | ₹47 Cr | Positive | |
| Mar2024 | ₹-201 Cr | Negative | |
| Mar2023 | ₹124 Cr | 345.56 | |
| Mar2022 | ₹28 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of AJANTA PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AJANTA PHARMA | ₹41,856.5 Cr | -0.6% | 9.1% | 25.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹464,331.0 Cr | 1.2% | 8.3% | 15.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹181,466.0 Cr | -0.2% | 3% | -0.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹165,952.0 Cr | 1.7% | 9.9% | 46.8% | Stock Analytics | |
| CIPLA | ₹116,229.0 Cr | -2.2% | 4.5% | -4.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,959.0 Cr | -9% | -2.1% | -1.8% | Stock Analytics | |
AJANTA PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AJANTA PHARMA | -0.6% |
9.1% |
25.7% |
| SENSEX | -0.3% |
4.9% |
-7% |
You may also like the below Video Courses